⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Avista Healthcare Partners and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Avista Healthcare Partners
↗New York, USA
Avista Healthcare Partners is a prominent New York-based private equity firm focused exclusively on the healthcare sector. Founded in 2005 as a spin-out from DLJ Merchant Banking Partners, the firm specializes in growth capital and leveraged buyout investments in middle-market companies.
Avista targets healthcare product and technology businesses, including pharmaceuticals, biotechnology, medical devices, and consumer health platforms. The firm is known for its operational approach, partnering with management teams to drive growth and build long-term value across its portfolio, which includes companies like Cosette Pharmaceuticals, Trillium Health Care Products, and EBI.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Private Equity / Healthcare Investment
SIZE & FINANCIALS
Employees:51-200
Founded:2005
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:Damier Group (Co-investor), Hamilton Lane (Investment partner)
COMPETITION
Position:Leader
Competitors:CCMP Capital, Court Square Capital Partners, MidOcean Partners, Metalmark Capital
LEADERSHIP
Key Executives:
Thompson Dean - Chairman
David Burgstahler - Co-Founder
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Avista Healthcare Partners. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.